A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Revolution Medicines, Inc.
Celldex Therapeutics
Revolution Medicines, Inc.
Silverback Therapeutics
IGF Oncology, LLC
University of Illinois at Chicago
Poniard Pharmaceuticals
Poniard Pharmaceuticals
Pharmacyclics LLC.